Current Drug Targets - Inflammation & Allergy

Continued as Inflammation & Allergy - Drug Targets

Personal Subscription
Volume: 4 Issue: 5, October

Editorial [Hot Topic: New Targets for Prevention and Treatment of Allergies (Guest Editor: Udo Herz)]

Volume:4   Issue: 5
Pp: 521-521
Udo Herz
DOI: 10.2174/156801005774322180
Published on: 01 March, 2012

Perinatal Events Affecting the Onset of Allergic Diseases

Volume:4   Issue: 5
Pp: 523-529
Udo Herz and Bryon Petschow
DOI: 10.2174/156801005774322144
Published on: 01 March, 2012

Skin Barrier Dysfunction and Systemic Sensitization to Allergens Through the Skin

Volume:4   Issue: 5
Pp: 531-541
Jessica Strid and Stephan Strobel
DOI: 10.2174/156801005774322199
Published on: 01 March, 2012

Pharmaceutical Treatment of Asthma in Children

Volume:4   Issue: 5
Pp: 543-549
Kai-Hakon Carlsen
DOI: 10.2174/156801005774322216
Published on: 01 March, 2012

Anti-IgE Therapy in Allergic Asthma

Volume:4   Issue: 5
Pp: 551-564
Claudia Rolinck-Werninghaus, Ulrich Wahn and Eckard Hamelmann
DOI: 10.2174/156801005774322162
Published on: 01 March, 2012

Mucosal Immunoregulation: Transcription Factors as Possible Therapeutic Targets

Volume:4   Issue: 5
Pp: 565-575
Aysefa Doganci, Markus F. Neurath and Susetta Finotto
DOI: 10.2174/156801005774322153
Published on: 01 March, 2012

Design of Protective and Therapeutic DNA Vaccines for the Treatment of Allergic Diseases

Volume:4   Issue: 5
Pp: 585-597
Richard Weiss, Peter Hammerl, Arnulf Hartl, Romana Hochreiter, Wolfgang W. Leitner, Sandra Scheiblhofer and Josef Thalhamer
DOI: 10.2174/156801005774322171
Published on: 01 March, 2012

Evidence of Probiotics in Prevention of Allergy and Asthma

Volume:4   Issue: 5
Pp: 599-604
Bengt Bjorksten
DOI: 10.2174/156801005774322135
Published on: 01 March, 2012